WHO has released new details regarding membership of the Guidelines Development Group (GDG) for development of new guidance on Hepatitis C self-testing in 2021. The meeting of the GDG will be held on 18–19 February 2021 and will focus on reviewing the latest evidence on Hepatitis C self-testing. The purpose of the meeting is to…
Category: Uncategorized
Cost-effectiveness of screening and treatment using direct-acting antivirals for chronic Hepatitis C virus in a primary care setting in Karachi, Pakistan
Nyashadzaishe Mafirakureva 1, Aaron G Lim 1, Gul Ghuttai Khalid 2, Khawar Aslam 2, Linda Campbell 1, Hassaan Zahid 2, Rafael Van den Bergh 3, Gregoire Falq 4, Camille Fortas 4, Yves Wailly 3, Rosa Auat 3, Dmytro Donchuk 3, Anne Loarec 4, Joanna Coast 1, Peter Vickerman 1 5, Josephine G Walker 1 Abstract Despite the availability of effective direct-acting antiviral (DAA) treatments for Hepatitis C virus (HCV) infection, many people remain undiagnosed and untreated. We assessed the cost-effectiveness of a Médecins Sans Frontières (MSF) HCV…
News: Government in Pakistan announces ambitious plan to eliminate hepatitis
The WHO reports that in Pakistan, 5 and 10 million people are affected with hepatitis B and C respectively. Thousands of new patients contract the disease every year due to lack of prevention, testing and treatment resources as well as inadequately screened blood transfusion, improperly sterilized invasive medical devices and unsafe injections. To address the…
Microelimination.org: resources for individuals and organizations interested in hepatitis C microelimination 